Guy Miller
Impact in
- Clinical Biochemistry top 2%
- Metabolism and Genetic Disorders
- Biochemistry top 5%
- Antioxidant Activity and Oxidative Stress
Papers in
-
- Metabolism and Genetic Disorders 5
-
- Antioxidant Activity and Oxidative Stress 4
- Co-authors
- William D. ShraderViktoria KheifetsMartin ThoolenJonathan HimmelfarbStephen D. PhinneyEllen McMonagleAkiko AmagataGregory M. Enns
- Journals
- Molecular Genetics and Metabolism (4 papers)Neurology (3 papers)Investigative Ophthalmology & Visual Science (3 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)
- Partner nations
- United StatesItalyBrazil
In The Last Decade
Guy Miller
26 papers receiving 930 citations
Peers
Comparison fields: 5 of 83
- Clinical Biochemistry 228
- Biochemistry 91
- Biochemistry 94
- Molecular Biology 620
- Nutrition and Dietetics 128
Countries citing papers authored by Guy Miller
This map shows the geographic impact of Guy Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Miller more than expected).
Fields of papers citing papers by Guy Miller
This network shows the impact of papers produced by Guy Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Miller. The network helps show where Guy Miller may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guy Miller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2022 | 9 | |
| 4 | 2018 | 149 | |
| 5 | 2017 | 19 | |
| 6 | 2016 | 1 | |
| 7 | EPI-743 (Quinone) therapy for Leber’s Hereditary Optic Neuropathy: the Brazil experience. | 2016 | 1 |
| 8 | 2016 | 3 | |
| 9 | 2016 | 13 | |
| 10 | EPI-743 May Improve Visual Acuity in LHON: Data from a Brazilian Cohort | 2014 | 1 |
| 11 | 2014 | 1 | |
| 12 | Treatment of Leber's hereditary optic neuropathy (LHON): Results using a novel quinone, EPI-743 | 2013 | 3 |
| 13 | 2012 | 66 | |
| 14 | 2012 | 149 | |
| 15 | 2012 | 27 | |
| 16 | 2011 | 70 | |
| 17 | 2011 | 148 | |
| 18 | 2011 | 11 | |
| 19 | 2007 | 85 | |
| 20 | 2003 | 91 |
About Guy Miller
Guy Miller is a scholar working on Clinical Biochemistry, Biochemistry, Ophthalmology, Internal Medicine and Molecular Biology, having authored 27 papers that have together received 945 indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (12 papers), ATP Synthase and ATPases Research (5 papers), Metabolism and Genetic Disorders (5 papers), Coenzyme Q10 studies and effects (4 papers), Antioxidant Activity and Oxidative Stress (4 papers), Genetic Neurodegenerative Diseases (3 papers), Drug-Induced Ocular Toxicity (3 papers) and Acute Myocardial Infarction Research (3 papers). The work is most often cited by research in Clinical Biochemistry (228 citations), Biochemistry (91 citations), Biochemistry (94 citations), Molecular Biology (620 citations) and Nutrition and Dietetics (128 citations). Guy Miller has collaborated with scholars based in United States, Italy and Brazil. Frequent co-authors include William D. Shrader, Viktoria Kheifets, Martin Thoolen, Jonathan Himmelfarb, Stephen D. Phinney, Ellen McMonagle, Akiko Amagata, Gregory M. Enns, A. Scott Hinman and Matthew B. Klein. Their work appears in journals such as Molecular Genetics and Metabolism, Neurology, Investigative Ophthalmology & Visual Science, Clinical Chemistry and Laboratory Medicine (CCLM) and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.